Literature DB >> 8192472

Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.

A Meier1, P Kirschner, B Springer, V A Steingrube, B A Brown, R J Wallace, E C Böttger.   

Abstract

Clarithromycin is a potent macrolide that has been used for treating infections with nontuberculous mycobacteria. Pairs of susceptible and resistant Mycobacterium intracellulare strains were obtained from patients with chronic pulmonary M. intracellulare infections undergoing monotherapy with clarithromycin. Nucleotide sequence comparisons of the peptidyltransferase region in 23S rRNAs from parental and resistant strains revealed that in three of six resistant strains, for which the MIC was > 32 micrograms/ml, a single base was mutated (Escherichia coli equivalent, A-2058-->G, C, or U). As the modification of adenine 2058 by dimethylation is a frequent cause of macrolide resistance in a variety of different bacteria, we suggest that mutation of A-2058 confers acquired resistance to clarithromycin in M. intracellulare.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192472      PMCID: PMC284463          DOI: 10.1128/AAC.38.2.381

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins.

Authors:  H G Wittmann; G Stöffler; D Apirion; L Rosen; K Tanaka; M Tamaki; R Takata; S Dekio; E Otaka
Journal:  Mol Gen Genet       Date:  1973-12-20

2.  Genetic studies of he ribosoml proteis in Escherichaoli. V. Mapp-ing of erythromycin resistance mutations which lea to alteration of a 50s ribosomal protein component.

Authors:  R Takata; S Osawa; K Tanaka; H Teraoka; M Tamaki
Journal:  Mol Gen Genet       Date:  1970

Review 3.  Structure of ribosomal RNA.

Authors:  H F Noller
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

4.  Identification of two erythromycin resistance mutations in the mitochondrial gene coding for the large ribosomal RNA in yeast.

Authors:  F Sor; H Fukuhara
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

5.  Erythromycin resistant mutants of Bacillus subtilis.

Authors:  K Tanaka; M Tamaki; S Osawa; A Kimura; R Takata
Journal:  Mol Gen Genet       Date:  1973-12-20

6.  Erythromycin and spiramycin resistance mutations of yeast mitochondria: nature of the rib2 locus in the large ribosomal RNA gene.

Authors:  F Sor; H Fukuhara
Journal:  Nucleic Acids Res       Date:  1984-11-26       Impact factor: 16.971

7.  Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved.

Authors:  B Weisblum; V Demohn
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

8.  Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.

Authors:  M Finken; P Kirschner; A Meier; A Wrede; E C Böttger
Journal:  Mol Microbiol       Date:  1993-09       Impact factor: 3.501

9.  Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics.

Authors:  R Skinner; E Cundliffe; F J Schmidt
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli.

Authors:  M Ettayebi; S M Prasad; E A Morgan
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

View more
  65 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Effect of drug concentration on emergence of macrolide resistance in Mycobacterium avium.

Authors:  K A Nash
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 4.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing.

Authors:  Marjo Haanperä; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.

Authors:  M Picardeau; A Varnerot; T Lecompte; F Brel; T May; V Vincent
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

7.  Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet?

Authors:  Sara Christianson; William Grierson; Joyce Wolfe; Meenu K Sharma
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

8.  Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria.

Authors:  Bettina Schulthess; Daniel Schäfle; Nicole Kälin; Tamara Widmer; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

Review 9.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

10.  Substrate requirements for ErmC' methyltransferase activity.

Authors:  P Zhong; S D Pratt; R P Edalji; K A Walter; T F Holzman; A G Shivakumar; L Katz
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.